glp 1 agonists on the market GLP-1 Receptor Agonist Valued at USD 62.86 Billion in 2025, Set to Grow at 17.5% CAGR Through 2034 GLP-1 Receptor Agonist Market Size

It is also considered by patients who want to support their body's natural healing processes without relying solely on conventional pain management approaches

In a study, 8 out of 10 men with psychogenic erectile dysfunction, who were able to achieve erections while sleeping, but unable to do so before sexual activity, treated with Melanotan II developed penile erections [6]

Another promising direction involves dissolving microneedles, which completely degrade upon administration, eliminating the need for disposal and improving patient compliance

Consistency across injection cycles matters more than perfection within a single cycle

Until then, experts are generally skeptical that GLP-1 RAs are a good idea for athletes who dont medically need them